News

2019.01.30News Release

Chugai Transfers Rights to Maruho for Oxarol^® Ointment 25μg/g and Oxarol^® Lotion 25μg/g, Therapeutic Agents for Keratosis including Psoriasis Vulgaris, and Marduox^® Ointment, a Therapeutic Agent for Psoriasis Vulgaris

2018.10.01News Release

National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment

2018.09.28News Release

Maruho Succeeds Manufacturing and Marketing Approval and Marketing Rights for Acne Vulgaris Treatment Agent "Differin^® Gel 0.1%"

2018.09.13News Release

Maruho Launches Blood-flow Accelerative/Skin-moisturizing Agent "Hirudoid^® Foam 0.3%"

2018.07.05News Release

Nestlé Skin Health and Maruho Release Renewed Itch Measurement App 'Itch Tracker' for Apple Watch on July 5, Maruho Receives Exclusive Rights in Japan

2018.03.01News Release

Maruho Succeeds Manufacturing and Marketing Approval and Marketing Rights for Reduction of Malodor Generated in Cancerous Cutaneous Ulcers Treatment "Rozex^® Gel 0.75%"

2018.02.16News Release

Maruho Receives Manufacturing and Marketing Approval for Blood-flow Accelerative/Skin-moisturizing Agent "Hirudoid^® Foam 0.3%"

2018.01.22News Release

Maruho Launches In Vitro Diagnostic "DermaQuick^® VZV"

2017.12.25News Release

Maruho and RaQualia Enter License Agreement for Selective Sodium Channel Blocker

2017.11.30News Release

Maruho and Asahi Kasei Pharma Announce Phase 3 Clinical Study Results of Famciclovir for the Treatment of Recurrent Herpes Simplex

2017.09.07News Release

Maruho Launches Anti-Herpes Virus Agent "Amenalief^® Tab. 200mg" in Japan

2017.09.01News Release

Maruho Receives Manufacturing and Marketing Approval and Insurance Coverage for In Vitro Diagnostic "Derma Quick^® VZV"

2017.08.01News Release

Maruho Succeeds Manufacturing and Marketing Approval for Acne Vulgaris Treatment "Epiduo^® Gel"

2017.07.11News Release

Maruho Launches Topical Scalp Psoriasis Treatment "Comclo^® Shampoo 0.05%" in Japan

2017.07.07News Release

Maruho Succeeds Marketing Approval for Anti-Atopic Dermatitis Agent "Protopic^® Ointment" in Japan

2017.07.03News Release

Maruho receives manufacturing and marketing approval for Anti-Herpes Virus Agent "Amenalief^® Tab. 200mg" in Japan